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A B S T R A C T
Maintaining production and economic viability in the face of resistance to multiple anthelmintic actives
is a challenge for farmers in many countries. In this situation, most farmers in New Zealand rely on the
use of combination products, containing multiple actives with similar spectra of activity, in order to main-
tain control. However, there are concerns that use of combinations, once resistance has already developed
to the individual actives, could rapidly lead to complete failure of all actives. This study followed seven
farms, previously diagnosed with resistance to at least two classes of anthelmintic, which were imple-
menting a tailored programme of ‘best practice parasite management’. The aim was to ascertain whether
the programmes, which included the almost exclusive use of combination anthelmintics, were able to
prevent resistance from developing further. Strategies implemented on each farm varied, but had con-
sistent underlying principles i.e. to avoid over-use of anthelmintics; to minimise parasite challenge to
susceptible stock; to maintain refugia of susceptibility and to ensure that only effective anthelmintics
were used. Annual faecal egg count reduction tests (FECRT) were undertaken in lambs on all farms to
monitor anthelmintic eﬃcacy over 5 years. The eﬃcacy of albendazole, ivermectin and levamisole was
calculated and the changes in eﬃcacy against Teladorsagia circumcincta assessed. Overall, there was a
signiﬁcant improvement in the effectiveness of both levamisole and ivermectin against T. circumcincta,
and a positive but non-signiﬁcant trend in eﬃcacy of albendazole, i.e. there was evidence for reversion
towards susceptibility. Hence, the almost exclusive use of combination anthelmintics, integrated with
other resistance management strategies, did not result in further resistance development despite all farms
exhibiting resistance to multiple actives at the outset. What-is-more, the measured increases in anthel-
mintic eﬃcacy suggests that adoption of best practice management strategies may extend the useful life
of anthelmintics even after resistance has been diagnosed.
© 2015 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
1. Introduction
Anthelmintic resistance in nematode parasites of grazing animals
is an expanding problem and is of major concern in many coun-
tries (Kaplan, 2004; Waghorn et al., 2006; Besier, 2007; Sutherland
and Leathwick, 2011). As anthelmintics are generally the corner-
stone of most parasite control programmes, the impact of parasites
which are resistant to these drugs can be considerable (Besier, 2007;
Sutherland et al., 2010; Miller et al., 2012; Stromberg et al., 2012).
In order to retain the effectiveness of anthelmintics for as long as
possible, it is essential that strategies are developed and imple-
mented which can slow or prevent the development of resistance
(Besier, 2007; Nielsen et al., 2014). With respect to nematode para-
sites of sheep, there has been extensive research over many years
aiming to increase our understanding of the factors inﬂuencing the
development of resistance, and itsmanagement once present (Barnes
et al., 1995; Leathwick et al., 2009; Leathwick and Besier, 2014). As
a result, for sheep at least, there is an array of established ap-
proaches for managing resistance (Leathwick and Besier, 2014).
Historically, one of the main strategies promoted to slow the de-
velopment of resistance was to alternate (rotate) the class of
anthelmintic used on an approximately annual basis (Donald et al.,
1980; Prichard et al., 1980; Waller et al., 1989; Coles and Roush,
1992). This recommendation was based on the expectation that if
there was a ﬁtness cost associated with being resistant then rotat-
ing anthelmintics would allow the opportunity for reversion towards
susceptibility to occur in the period when alternative drugs were
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used. Also, it was considered that by not exposing individual worms
to more than one class of anthelmintic, selection for resistance to
multiple actives was less likely to occur (Prichard et al., 1980). The
practice of rotating different anthelmintic classes annuallywaswidely
adopted in some countries (Kettle et al., 1983; Waller et al., 1989;
Lawrence et al., 2007; Sargison et al., 2007) and is still promoted
today in some countries and classes of animals (McMahon et al.,
2013a). However, in the interim resistance has continued to develop
and resistance to multiple anthelmintic classes is now well estab-
lished on some farms (van Wyk et al., 1997; Waghorn et al., 2006;
Le Jambre et al., 2010; Torres-Acosta et al., 2012; McMahon et al.,
2013b; Geurden et al., 2014).
An alternative approach to drug use was suggested by early mod-
elling studies (Smith, 1990; Barnes et al., 1995) which showed that
simultaneously using multiple actives, with similar spectra of ac-
tivity, had the potential to dramatically slow the development of
resistance. Subsequently, commercial interests developed and
marketted such combination anthelmintic products and these are
now used extensively in some countries, but are still not available
in others (Bartram et al., 2012; Geary et al., 2012). Subsequent mod-
elling and empirical studies have continued to support the use of
combinations to slow the development of resistance (Learmount
et al., 2012; Leathwick, 2012; Leathwick et al., 2012). However, both
modelling and empirical studies indicate that when the frequency
of resistance alleles is already high in a population, combinations
lose much of their ability to slow the further development of re-
sistance (Leathwick et al., 2012). This has been used as an argument
against the use of combinations (Coles and Roush, 1992) and a per-
ception has developed that their use, once resistance to multiple
anthelmintic classes has already established, will result in the further
and rapid escalation of resistance to all of the different classes. This
perception has created a dilemma for those farmers and their ad-
visors who, prior to the release of new anthelmintic actives
(monepantel (Kaminsky et al., 2008) and derquantel (Little et al.,
2010)) found themselves in a situation where no single active
product would work effectively on their farm and the only prod-
ucts which could be used to maintain control were combinations.
Between 2010 and 2013, a four year extension programme was
run to implement and evaluate parasite and resistance manage-
ment programmes on commercial sheep and beef farms throughout
New Zealand (Rhodes et al., 2011). One of the principle aims of this
programme was to implement strategies which would maintain or
improve on-farm productivity whilst preventing any further in-
crease in the resistance status of parasites on the farms. Given that
most of the sheep farms enrolled in this programme already had
signiﬁcant resistance to at least two anthelmintic classes, routine
use of combination anthelmintics was inevitable. This situation,
therefore, presented an opportunity to follow the progress of an-
thelmintic resistance on a number of farms under integrated
resistance management programmes which included, along with
other refugia and management practices, the almost exclusive use
of combination anthelmintics.
2. Materials and methods
2.1. The best practice parasite management programme
The Best Practice Parasite Management programme (BPPMP) was
an industry-funded programme which aimed to develop and im-
plement parasite and resistance management programmes on a
diverse range of farms throughout the country and to evaluate their
performance over time (Rhodes et al., 2011). Details of the pro-
gramme will be published elsewhere, but brieﬂy the intent was to
design a parasite management programme speciﬁcally to ﬁt the re-
quirements of each farm and farmer, in order to maintain or improve
production and proﬁtability, whilst ensuring that the eﬃcacy of
anthelmintics did not decline from its initial level.
The programme involved an annual visit to the farm by the farm
veterinarian, a parasitologist and an agricultural consultant. A whole-
of-farm approach was taken such that at each visit a comprehensive
review was undertaken of farm practices and events (e.g. pur-
chase and sale of stock, livestockmanagement, fertiliser applications,
and crops grown) over the previous 12 month period along with a
detailed review of the current animal health programme. Modiﬁ-
cations to the plan were then discussed, informed by anymonitoring
data, and changes agreed upon for implementation in the follow-
ing year along with a programme tomonitor parasite levels (through
regular faecal nematode egg counts (FEC) and coprocultures). Over
the following 12 months the plan was implemented by the farmer
with assistance from the veterinarians.
2.2. Resistance management strategies
The suite of parasite control and resistance management strat-
egies implemented varied depending on the characteristics of each
farm, so no two farms applied the same set of strategies in the same
way. There were, however, some consistent underlying principles
which can be grouped as:
1. use effective anthelmintic products i.e. on the basis of annual ef-
ﬁcacy tests, select products which will achieve high eﬃcacy
against all worm species (at least 95%). Because all seven farms
were known to have resistance to at least two anthelmintic
classes, this required the use of combination products and/or new
actives.
2. avoid over-use of anthelmintics i.e. maintain a structured pre-
ventive programme of treatments to lambs (Vlassoff and
Brunsdon, 1981) with all other treatments on the basis of dem-
onstrated need (i.e. signs of illthrift or FEC) (Leathwick and Besier,
2014).
3. do not administer anthelmintic treatments at intervals shorter
than 28 days to allow for some limited contamination of pas-
tures with susceptible genotypes after the pre-patent period of
new infection.
4. minimise or eliminate the use of anthelmintics with persistent
activity (Leathwick and Besier, 2014).
5. administer a single treatment, containing a new anthelmintic
class, to lambs in late summer to remove resistant genotype
worms which have accumulated over previous treatments
(Leathwick and Hosking, 2009).
6. maximise the opportunities for retention of unselected geno-
types (i.e. to maintain refugia). The principal method used to
achieve this was to minimise the treatment of adult sheep and
ensure that treated lambs and untreated ewes grazed over the
same pastures as much as possible. Where this was not practi-
cal other approaches were used (Leathwick et al., 2008; Leathwick
and Besier, 2014).
7. maximise the use of integrated grazing (cattle, deer, sheep) and
crops to minimise parasite challenge to susceptible stock, and
adjust anthelmintic treatment schedules accordingly.
8. ensure that anthelmintic treatments did not coincide with a shift
to pastures likely to have low numbers of infective larvae unless
other strategies were in place to ensure adequate refugia (e.g.
treated lambs followed by untreated adult sheep) (Waghorn et al.,
2009).
9. effective quarantine procedures to prevent the introduction of
resistant genotypes with stock transferred onto the farm
(Leathwick and Besier, 2014).
Following each annual visit by the advisory team, throughout
the course of the programme, each farmer was allocated a subjec-
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tive scoring for their level of adoption of practices within each of
the above categories (Table 1).
2.3. Monitoring anthelmintic eﬃcacy
An annual faecal egg count reduction test (FECRT) was under-
taken on all farms tomonitor anthelmintic eﬃcacy over time.Where
feasible this was continued after the programme ﬁnished, so that
anthelmintic eﬃcacy was monitored for ﬁve years on most
farms.
Each year, a mob of at least 60 lambs was set aside before
weaning, and these animals were monitored for FEC and re-
mained untreated with anthelmintics until the mean count from
10 samples reached approximately 750 eggs per g faeces (epg).
Where-ever possible the test was conducted on lambs which had
never been treated previously with anthelmintic, thereby remov-
ing the possibility that previous treatments would bias the result
by not completely removing all worm genotypes. The veterinarian
was sent a kit containing everything needed to carry out the test
including the anthelmintics, which ensured that all tests were con-
ducted using the same anthelmintic products, which in most cases
came from the same container. Faecal samples were couriered to
a central laboratory for processing so that all processing was carried
out by the same personnel.
Each FECRT comprised 4 treatment groups each of at least 12
animals. On day 0 all animals were weighed, sampled for FEC and
then administered either; albendazole at 5.0 mg/kg live weight
(Albendazole, Merial New Zealand Ltd), levamisole at 7.5 mg/kg live
weight (Levicare Hi Mineral, Merial New Zealand Ltd), ivermectin
at 0.2 mg/kg live weight (Ivomec Liquid for sheep & goats, Merial
New Zealand Ltd) or were left as an untreated control. Seven to ten
days after treatment a second faecal sample was collected from all
animals.
Samples were kept cool and couriered over night to the labo-
ratory. Faecal egg counts were performed using amodiﬁedMcMaster
method (Lyndal-Murphy, 1993) where one egg seen equated to
50 epg. Faeces from the post-treatment samples was pooled by treat-
ment group and cultured at 22 °C for 14 days before undergoing
baermannisation to extract the third stage larvae (L3) (Hendrix,
1998). Individual L3 (N = 96) from each culture were identiﬁed to
species using a multiplexed PCR technique with primers designed
to target unique sequencemotifs present in the second internal tran-
scribed spacer region of the ribosomal DNA of each of the larval
species (Bisset et al., 2014; Waghorn et al., 2014). The proportion
of each nematode species in the culture from the control samples
was used to apportion FEC to species in the pre-test treated groups.
Similarly, FEC in the post-treatment samples was apportioned to
species based on the proportion of each species in the post-
treatment samples (McKenna, 1996). These numbers were then used
to calculate the eﬃcacy (reduction in FEC) of treatment for each
species of nematode using the equation below (Presidente, 1985;
Waghorn et al., 2006). For the purpose of this study anthelmintic
resistance was deﬁned as a <95% reduction in FEC (McKenna, 1994).
Ninety-ﬁve per cent conﬁdence intervals around the eﬃcacy were
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Resistance was mostly commonly identiﬁed in Teladorsagia
circumcincta, and this was the only species in which resistance to
ivermectin was identiﬁed. Therefore, this was the only nematode
species for which resistance to all three of the tested anthelmintics
was found. Seven farms were identiﬁed as having resistance to two
or more anthelmintics in this nematode species at the beginning
of the BPPM programme, and as the aim was to examine any pos-
sible worsening of resistance over the course of the programme,
analysis of the eﬃcacy data was restricted to this species.
Separate analyses were conducted for each of the three actives.
Linear regression, weighted by the apportioned FEC (so eﬃcacy
ﬁgures based on low egg counts had less inﬂuence than those based
on higher numbers) was used. Only linear regression models were
explored due to some farms not having data for all 5 years (thus
non-linear models have not been considered). Since the slopes and
intercepts associated with the linear regressionmodel ﬁtted for each
of the seven farms may be different, the ‘Random coeﬃcient re-
gression models’ (Raja, 1984) were utilised. Modelling was
undertaken using the lmer function of the package lme4 of the R
software (R Core Team, 2014).
3. Results
Overall, all farmers made consistent efforts to adopt most of the
resistance management practices worked out with their advisors
(Table 1). The majority of anthelmintic treatments were with com-
bination products, the only exceptions being a strategic annual
treatment with the new active monepantel on 5 farms and a single
Table 1
The anthelmintics used, the annual number of treatments to lambs and the mean interval between these treatments, along with a qualitative scoring on the level of adop-
tion by farmers of best practice parasite management practices, for each of the 7 farms in the study.
Factor Farm
B D H K M P W

















Average annual number of treatments to lambs 9 7 10 7 8 7 7
Average interval between treatments (days) 28 29 30 28 29 28 39
Avoid over-use of anthelmintics ✓✓✓ ✓✓✓ ✓✓✓ ✓✓✓ ✓✓ ✓✓✓ ✓✓✓
No long acting treatments ✓✓✓ ✓✓✓ ✓✓✓ ✓✓✓ ✓✓ ✓ ✓✓✓
Use a new active in summer ✓✓✓ ✓✓✓ ✓✓✓ ✓✓✓ ✓✓✓ ✓✓✓ ✓✓✓
Maintain ‘Refugia’ of susceptibility ✓✓✓ ✓✓✓ ✓✓✓ ✓✓✓ ✓✓ ✓✓✓ ✓✓
Integrated grazing ✓✓✓ ✓✓✓ ✓✓✓ ✓✓✓ ✓ ✓✓ ✓✓✓
No treat and shift ✓✓✓ ✓✓✓ ✓✓✓ ✓✓✓ ✓✓ ✓✓ ✓✓✓
Effective quarantine ✓✓✓ ✓✓✓ ✓✓✓ ✓✓✓ ✓✓✓ ✓✓✓ ✓✓✓
✓, low level of adoption; ✓✓, medium level of adoption; ✓✓✓, high level of adoption.
AL, Abamectin, levamisole; AD, Abamectin, derquantel; ABL, Abamectin, levamisole, oxfendazole/albendazole; Mon, Monepantel; BL, Albendazole, levamisole; Mox, Moxidectin.
11D.M. Leathwick et al./International Journal for Parasitology: Drugs and Drug Resistance 5 (2015) 9–15
annual treatment with moxidectin for control of Haemonchus
contortus on farm M. Although, the detail of how strategies were
implemented invariably differed between farms the efforts made
Table 2
Eﬃcacy data for Teladorsagia circumcincta against each active tested (A – Albendazole, B – Levamisole and C – Ivermectin) with 95% conﬁdence intervals (CI) for the 7 farms
over the 4 years of the project and the one follow up year. The faecal egg counts allocated to T. circumcincta based on the proportion of this species found in the control
cultures and used as a covariant in the analysis are also given.
Year of test
2010 2011 2012 2013 2014
(A) Albendazole
Farm B % eﬃcacy 51 86 92 NT 71
95% CI 12–73 79–91 89–93 9–92
FEC 175 1101 875 73
Farm D % eﬃcacy 96 98 100 100 100
95% CI 95–97 97–99 97–100 96–100 98–100
FEC 625 153 118 30 86
Farm H % eﬃcacy 96 100 98 95 98
95% CI 93–98 97–100 94–99 93–96 96–99
FEC 21 114 25 35 72
Farm K % eﬃcacy 40 NT 100 67 96
95% CI −30–72 95–100 55–77 94–98
FEC 84 44 242 265
Farm M % eﬃcacy −9 70 92 97 83
95% CI −55–24 53–81 69–98 94–99 59–92
FEC 53 596 160 1007 75
Farm P % eﬃcacy 87 53 73 53 NT
95% CI 78–92 24–71 61–80 25–69
FEC 88 48 30 23
FarmW % eﬃcacy 92 NT 97 56 91
95% CI 91–93 85–99 31–73 68–97
FEC 285 32 102 104
(B) Levamisole
Farm B % eﬃcacy 27 92 98 NT 56
95% CI −1–48 85–95 97–99 17–79
FEC 175 1101 875 73
Farm D % eﬃcacy 75 99 96 98 98
95% CI 50–87 98–100 93–98 97–100 90–100
FEC 625 153 118 30 86
Farm H % eﬃcacy 91 98 100 98 94
95% CI 64–98 85–100 93–100 75–100 78–98
FEC 21 114 25 35 72
Farm K % eﬃcacy 88 NT 100 95 94
95% CI 80–93 96–100 84–99 84–98
FEC 84 44 242 265
Farm M % eﬃcacy 70 99 98 100 77
95% CI 8–90 93–100 76–100 99–100 50–88
FEC 53 596 160 1007 75
Farm P % eﬃcacy 36 94 96 89 NT
95% CI −19–66 47–99 90–98 66–96
FEC 88 48 30 23
FarmW % eﬃcacy 78 NT 99 86 92
95% CI 65–86 98–100 59–95 78–97
FEC 285 32 102 104
(C) Ivermectin
Farm D % eﬃcacy 93 98 100 100 100
95% CI 79–97 95–99 98–100 96–100 97–100
FEC 625 153 118 30 86
Farm H % eﬃcacy 90 100 33 97 95
95% CI 52–98 98–100 −131–75 91–99 76–99
FEC 21 114 25 35 72
Farm K % eﬃcacy 10 NT 79 54 95
95% CI −155–68 28–94 15–76 84–98
FEC 84 44 242 265
Farm M % eﬃcacy −128 64 66 97 71
95% CI −237–−55 45–77 50–77 93–98 53–80
FEC 53 596 160 1007 75
Farm P % eﬃcacy 82 72 100 90 NT
95% CI 42–95 −95–96 96–100 74–96
FEC 88 48 30 23
FarmW % eﬃcacy 58 NT 99 97 67
95% CI 29–75 93–100 73–100 12–88
FEC 285 32 102 104
NT, not tested.
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by the farmers resulted in scores of 3 (on a scale of 0–3) for most
resistance management practices (Table 1).
At the start of the BPPMP, three of the 10 sheep farms had
T. circumcincta resistant to two classes of anthelmintic and four had
populations resistant to all 3 classes. Several farms had serious
resistance to all 3 actives. For example, Farm M had eﬃcacies for
albendazole, levamisole and ivermectin of 0%, 70% and 0%, respective-
ly,whilst FarmKhad eﬃcacies of 40%, 88% and 10% for the same actives
(Table 2).
Across the 7 farms, the eﬃcacy of albendazole against
T. circumcincta averaged 66% in year one, ranging from 0 to 96%. At
the end of the 5 years the average eﬃcacy had increased to 90% and
ranged from 71 to 100%. Although the regression had a positive slope
of 3.8, this was not signiﬁcant (p = 0.17) (Fig. 1a).
The eﬃcacy of levamisole against T. circumcincta also averaged
66% in year one with a range of 27 to 91% across the 7 farms. By
year 5 the average eﬃcacy was 85% with a range of 56 to 98%. The
slope of the linear regression was 5.4 which was signiﬁcant with
p = 0.04 (Fig. 1b).
The eﬃcacy of ivermectin against T. circumcincta averaged 55%
in year one with a range of 0 to 93%. By year 5 the average had in-
creased to 86% and the range reduced to 67 to 100%. With a positive
slope of 8.6 this increase in eﬃcacy was also signiﬁcant with p = 0.01
(Fig. 1c). Farm B was not included in the ivermectin analysis due
to high eﬃcacy with this active throughout the study resulting in
no variance.
In the ﬁnal FECRT, three farms were still classiﬁed as resistant
to all three actives; one farmwas resistant to two actives; two farms
were resistant to one active and one farm had no resistance to the
three actives. The eﬃcacy of the actives on the three farms still
showing triple resistance had increased, in some cases dramatical-
ly. For example, Farm M had ﬁnal eﬃcacies for albendazole,
levamisole and ivermectin of 83%, 77% and 71%, respectively, whilst
Farm K had eﬃcacies of 96%, 94% and 95% for the same actives
(Table 2).
4. Discussion
The purpose of this study was to monitor the eﬃcacy (i.e. level of
resistance) in T. circumcincta under best practice parasite manage-
ment in order to ascertain whether the strategies implemented were
able to prevent resistance frombecoming anyworse. On the seven farms
which started the programme with resistance to at least two classes
of anthelmintic, not only did resistance not get any worse, but overall
there was a signiﬁcant improvement in the effectiveness of both
levamisole and ivermectin i.e. there was evidence for some reversion
towards susceptibility. This result was unexpected for a number of
reasons. Firstly, as resistance was already well advanced on all these
farms, it seemed reasonable to expect that any initial ﬁtness cost as-
sociated with resistant genotypes would have been eroded by re-
association of resistance and ﬁtness traits during the selection process
(Kelly et al., 1978;Martin et al., 1988;Maingi et al., 1990; Prichard, 1990).
Secondly, all these farms routinely used combination anthelmintics
throughout the BPPMP, and so there seemed little opportunity for any
release from selection which would be an expected requirement for
reversion to occur (Prichard, 1990). Thirdly, on some farms the eﬃca-
cy levels were so low at the start of the BPPMP that a further rapid
decline in eﬃcacy might have been expected under continued selec-
tion (Coles and Roush, 1992). Clearly this did not happen.
A recent modelling study may offer at least a partial explana-
tion for these ﬁndings (Leathwick, 2013). This study compared the
effect of using drugs in combination with an annual rotation, under
different levels of ﬁtness cost associated with resistant genotypes,
and assumed that ﬁtness costs were additive when worms carried
multiple sets of resistance genes i.e. that worms carrying multiple

















































Fig. 1. Eﬃcacy of (a) albendazole, (b) levamisole and (c) ivermectin against
Teladorsagia circumcincta as measured by faecal egg count reduction on 7 sheep farms
over 5 years.
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drug. The results indicated that reversion was more likely to occur
(i.e. at lower ﬁtness costs) when drugs were used in combination
than in rotation because the combination removed all resistant worm
genotypes except those simultaneously carrying multiple sets of re-
sistance genes, which were the least ﬁt. Further, it was found that
the size of the worm population in refugia was also important, with
resistance being delayed more and reversion occurring at lower
ﬁtness costs when a larger proportion of the worm population was
not exposed to treatment. There is evidence to support a ﬁtness cost
in being resistant, studies on T. colubriformis and H. contortus have
shown reduced establishment in resistant isolates (Maclean et al.,
1987; Maingi et al., 1990). Scott and Armour (1991) andMaingi et al.
(1990) also found that the proportion of viable eggs being pro-
duced by resistant isolates of H. contortus was much less than that
produced by susceptible isolates.
The BPPMP applied a number of resistance management strat-
egies to every farm (Table 1) and the set of strategies was invariably
different, either in composition or in the manner in which they were
applied. Therefore, it is not possible to determine which strategies
contributed, or had the greatest impact, on the results reported here.
Indeed, it is likely that the different mixtures of strategies imple-
mented on different farms contributed to the variability in degree
of reversion seen on different farms. However, given that along with
the use of effective combination anthelmintics, substantial efforts
were also made to avoid unnecessary treatments and ensure the
maximum refugia consistent with production targets, it seems highly
likely that the complex of strategies was effective rather than any
individual approach. The results are, however, consistent with the
hypothesis raised by Leathwick (2013) that reversion to suscepti-
bility can occur when combination anthelmintics are used, especially
when high levels of refugia are also maintained.
In Australia and New Zealand, farmers are often required to use
combination anthelmintics just to maintain control, unless they can
afford the additional cost of using products containing new actives
(McKenna, 2010; Leathwick and Besier, 2014). The results of this
study offer some encouragement for these farmers and their long-
term future in that the use of combination anthelmintics against
worm populations which were already demonstrating well devel-
oped resistance to multiple actives did not result in any escalation
towards total treatment failure. In fact, for all the farmers in-
volved in this study, the eﬃcacy of the double or triple combination
anthelmintics which they were using actually increased over the
duration of the BPPMP. Clearly, this would have increased their ability
tomaintain worm control and improved the long-term sustainability
of their farming operation. On some farms this increase in eﬃcacy
was substantial e.g. Farm M, where eﬃcacy increased from 0% for
two drugs in year one to around 80% by the 5th year for all the drugs.
It must, however, be emphasised that in this study a suite of changes
weremade to achieve this goal and that just switching to use of com-
bination drenches, without addressing other issues such as the size
of the selection pressure and maintaining refugia of susceptibility,
may not produce the same result.
The key ﬁnding from this study is that when anthelmintics con-
taining multiple actives were used against worm populations with
varying levels of resistance to two or more of these actives, resis-
tance did not get worse. What-is-more, evidence was found for
signiﬁcant reversion towards susceptibility. It must be noted,
however, that combination anthelmintics were not used in isola-
tion from other resistance management strategies, and so it cannot
be assumed that combinations alone would have achieved this
outcome. The results are consistent with the ﬁndings of a recent
modelling study which indicated that reversion towards suscepti-
bility is feasible when using anthelmintics in combination if
individuals resistant to multiple actives are less ﬁt than those re-
sistant to only one (Leathwick, 2013). Work is currently underway
to determine whether differences in ﬁtness between isolates and
genotypes might explain these results.
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